Finally… YOU can beat Wall St Pros with THIS…
Hedge funds and billionaires have pushed around Main Street investors for long enough.

That's why I’m going to make my most popular manual "5 Secret Trading Strategies to Win Every Day in the Market" available for FREE for anyone who wants it.
Download your copy now.

MEDS Insider Trading (TRxADE HEALTH)

Insider Ownership Percentage: 53.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $83,467.00

TRxADE HEALTH Insider Trading History Chart

This chart shows the insider buying and selling history at TRxADE HEALTH by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TRxADE HEALTH Share Price & Price History

Current Price: $5.08
Price Change: Price Decrease of -0.1 (-1.93%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for MEDS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tesla's Downfall is Near…. Here's The Next Big Thing
This Tech Giant is About to Rock the Electric Vehicle Market and Take Over Tesla.

Click Here to see which company is secretly destroying TESLA.
Learn more.

TRxADE HEALTH Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/21/2021Michael L PetersonDirectorSell900$4.45$4,005.005,387View SEC Filing Icon  
4/19/2021Michael L PetersonDirectorSell900$4.68$4,212.006,287View SEC Filing Icon  
4/19/2021Prashant PatelPresidentSell7,500$4.39$32,925.001,252,500View SEC Filing Icon  
12/14/2020Donald G FellDirectorSell500$5.30$2,650.008,487View SEC Filing Icon  
12/14/2020Prashant PatelPresidentSell7,500$5.29$39,675.001,260,000View SEC Filing Icon  
7/13/2020Prashant PatelPresidentSell500$5.71$2,855.001,274,500View SEC Filing Icon  
See Full Table
Insider Selling at TRxADE HEALTH?
Sign-up to receive's daily insider buying and selling report for TRxADE HEALTH and related companies.

SEC Filings (Institutional Ownership Changes) for TRxADE HEALTH (NASDAQ:MEDS)

5.98% of TRxADE HEALTH stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MEDS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TRxADE HEALTH Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/17/2021Virtu Financial LLC21,217$94K0.0%N/A0.260%Search for SEC Filing on Google Icon
8/13/2021Blueshift Asset Management LLC13,354$59K0.0%N/A0.164%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC20,510$90K0.0%-69.8%0.251%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.138,631$0.61M0.0%N/A1.699%Search for SEC Filing on Google Icon
8/10/2021National Asset Management Inc.266,500$1.18M0.0%-3.3%3.266%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC110,700$0.58M0.0%+176.1%1.368%Search for SEC Filing on Google Icon
4/19/2021International Assets Investment Management LLC5,500$29K0.0%+120.0%0.068%Search for SEC Filing on Google Icon
2/11/2021Heartland Advisors Inc.250,000$1.32M0.1%-16.7%3.089%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC40,100$0.21M0.0%N/A0.495%Search for SEC Filing on Google Icon
2/8/2021Royce & Associates LP20,700$0.11M0.0%-90.5%0.256%Search for SEC Filing on Google Icon
2/4/2021National Asset Management Inc.85,750$0.45M0.0%N/A1.060%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.10,426$65K0.0%+28.9%0.129%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TRxADE HEALTH, Inc. provides an online platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. The firm operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. It also provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.
Read More on TRxADE HEALTH

Today's Range

Now: $5.08
Low: $5.01
High: $5.17

50 Day Range

MA: $5.07
Low: $4.66
High: $5.69

52 Week Range

Now: $5.08
Low: $3.10
High: $10.82


45,403 shs

Average Volume

2,031,186 shs

Market Capitalization

$41.46 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of TRxADE HEALTH?

TRxADE HEALTH's top insider investors include:
  1. Prashant Patel (President)
  2. Donald G Fell (Director)
  3. Michael L Peterson (Director)

Who are the major institutional investors of TRxADE HEALTH?

TRxADE HEALTH's top institutional shareholders include:
  1. National Asset Management Inc. — 3.27%
  2. Vanguard Group Inc. — 1.70%
  3. Virtu Financial LLC — 0.26%
  4. Geode Capital Management LLC — 0.25%
  5. Blueshift Asset Management LLC — 0.16%

Which institutional investors are selling TRxADE HEALTH stock?

Within the last quarter, MEDS stock was sold by these institutional investors:
  1. Geode Capital Management LLC
  2. National Asset Management Inc.
In the last year, company insiders that have sold TRxADE HEALTH company stock include:
  1. Prashant Patel (President)
  2. Donald G Fell (Director)
  3. Michael L Peterson (Director)

Which institutional investors are buying TRxADE HEALTH stock?

During the previous quarter, MEDS stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Virtu Financial LLC
  3. Blueshift Asset Management LLC
MarketBeat's Top 5 Stock Picks - Just Released
MarketBeat has just released five new trading ideas, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.
View the Stocks Here